Medial EarlySign is helping transition clinical laboratories from processing samples and providing accurate lab results, to providing more sophisticated interpretation of lab results that look not only at current values but also trends and patterns in medical data. Our sophisticated machine learning solutions provide laboratories with opportunities to aid physicians in making informed, real-time decisions for patient risk stratification.
Medial EarlySign’s AlgoAnalyzer™ platform integrates quickly and easily with hospital laboratories’ existing IT and workflows, and manages preliminary data handling activities like standardization and normalization. This ensures the interoperability of medical data so that a healthcare organization’s IT systems and our AlgoMarker™ clinical risk predictors currently under development can properly exchange and interpret it.
Contact us today to learn more about Medial EarlySign’s laboratory risk stratification solutions.